These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7809452)

  • 21. [Lipid parameters in a homogeneous population sample in relation to age and sex].
    Luti R; Neri A; Brunori P
    Quad Sclavo Diagn; 1988; 24(1-4):179-83. PubMed ID: 3268910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alcohol and hyperlipoproteinemia].
    Reuter W
    Z Arztl Fortbild (Jena); 1983; 77(7):290-3. PubMed ID: 6858231
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipid risk factors in patients requiring arterial reconstruction.
    Seeger JM; Silverman SH; Flynn TC; Bailey JC; Klingman NV; Lawson GA; Borgeson MD; Barratt EJ
    J Vasc Surg; 1989 Oct; 10(4):418-24. PubMed ID: 2795767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
    Pados G; Kusztos D; Németh-Csóka M; Valyon M; Farkas K
    Ther Hung; 1983; 31(2):59-61. PubMed ID: 6571183
    [No Abstract]   [Full Text] [Related]  

  • 25. Study of blood lipid content and occurrence of hyperlipoproteinemias in hypertensive patients of various age.
    Tokar AV; Chayalo PP; Rudaya ES
    Z Alternsforsch; 1985; 40(1):41-6. PubMed ID: 3976251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting and treating dyslipoproteinemias.
    Horlick L
    CMAJ; 1990 Oct; 143(7):607-9. PubMed ID: 2207913
    [No Abstract]   [Full Text] [Related]  

  • 28. The physical structure of low-density lipoprotein in hyperlipoproteinemias and atherosclerosis.
    Bihari-Varga M; Gruber E; Tölgyesi F
    Monogr Atheroscler; 1986; 14():173-8. PubMed ID: 3736559
    [No Abstract]   [Full Text] [Related]  

  • 29. [New results of studies of plasma lipoprotein metabolism and the pathogenesis of hyperlipoproteinemias].
    Szollár L
    Orv Hetil; 1984 Oct; 125(43):2599-609. PubMed ID: 6493768
    [No Abstract]   [Full Text] [Related]  

  • 30. Atherogenesis: why women live longer than men.
    Hazzard WR
    Geriatrics; 1985 Jan; 40(1):42-51, 54. PubMed ID: 3965355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physical activity and dyslipoproteinemia].
    König D; Deibert P; Dickhuth HH; Berg A
    MMW Fortschr Med; 2004 Jul; 146(27-28):34-7. PubMed ID: 15526660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HDL-cholesterol--active or passive participant in the pathogenesis of atherosclerosis? (II)].
    Artenie A; Artenie R; Ungureanu D; Botnariu G; Anisies E; Ionescu SD; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):503-8. PubMed ID: 15832963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical aspects of the problem of hyperlipoproteinemia and age].
    Reuter W
    Z Gesamte Inn Med; 1981 Mar; 36(5):141-5. PubMed ID: 7018098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipid determination in current medical practice].
    Bakir R; Chanu B; Rouffy J
    Ann Dermatol Venereol; 1986; 113(9):855-9. PubMed ID: 3827091
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serum lipid and lipoprotein levels in populations of Beijing].
    Li JZ
    Zhonghua Yi Xue Za Zhi; 1988 Jun; 68(6):327-31, 24. PubMed ID: 3228725
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.
    Hahn R; Oette K; Mondorf H; Finke K; Sieberth HG
    Atherosclerosis; 1983 Sep; 48(3):279-88. PubMed ID: 6579964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver].
    Simon K; Kowalewski W; Dobracki W
    Przegl Lek; 1987; 44(11):746-50. PubMed ID: 3447241
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gender-specific differences of risk factors of atherosclerosis. A study of 3,850 Vienna employees].
    Stelzeneder M; Weiss K; Katzenschlager R; Rauscha F; Richter H; Harmuth P; Pidlich J; Widhalm K; Sinzinger H
    Wien Med Wochenschr; 1993; 143(12):322-9. PubMed ID: 8212720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipoprotein metabolism and atherosclerosis--experimental principles].
    Hüttinger M; Dudczak R
    Vasa Suppl; 1987; 20():52-5. PubMed ID: 3480607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.